CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy

Human Molecular Genetics

Volumn 24, Issue 13, 2015, Pages 3718-3731

  Charton, Karine ^a   Sarparanta, Jaakko ^b   Vihola, Anna ^b   Milic, Astrid ^a   Jonson, Per Harald ^b   Suel, Laurence ^a   Luque, Helena ^b   Boumela, Imène ^a   Richard, Isabelle ^a   Udd, Bjarne ^b,c,d  

^a GÉNÉTHON   (France)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN 3; CONNECTIN; CALPAIN; CAPN3 PROTEIN, HUMAN; CAPN3 PROTEIN, MOUSE; MUSCLE PROTEIN; PROTEIN BINDING; PROTEIN KINASE; TITIN PROTEIN, MOUSE; TTN PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INDUCED MUTATION; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROCESSING; SEQUENCE ANALYSIS; SKELETAL MUSCLE; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMISTRY; DISTAL MYOPATHY; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; PROTEIN DEGRADATION; PROTEIN MOTIF;

AMINO ACID MOTIFS; ANIMALS; CALPAIN; CONNECTIN; DISTAL MYOPATHIES; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; PROTEIN BINDING; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS;

EID: 84936743355     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv116     Document Type: Article

References (65)

1. Linke, W.A. and Hamdani, N. (2014) Gigantic business: titin properties and function through thick and thin. Circ. Res., 114, 1052-1068.
2. Sorimachi, H. and Ono, Y. (2012) Regulation and physiological roles of the calpain system in muscular disorders. Cardiovasc. Res., 96, 11-22.
3. Ojima, K., Ono, Y., Doi, N., Yoshioka, K., Kawabata, Y., Labeit, S. and Sorimachi, H. (2007) Myogenic stage, sarcomere length, and protease activity modulate localization of muscle-specific calpain. J. Biol. Chem., 282, 14493-14504.
4. Keira, Y., Noguchi, S., Minami, N., Hayashi, Y.K. and Nishino, I. (2003) Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle. J. Biochem., 133, 659-664.
5. Taveau, M., Bourg, N., Sillon, G., Roudaut, C., Bartoli, M. and Richard, I. (2003) Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol. Cell. Biol., 23, 9127-9135.
6. Duguez, S., Bartoli, M. and Richard, I. (2006) Calpain 3: a key regulator of the sarcomere? FEBS J., 273, 3427-3436.
7. Beckmann, J.S. and Spencer, M. (2008) Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance. Neuromuscul. Disord., 18, 913-921.
8. Tao, T., Shi, H., Guan, Y., Huang, D., Chen, Y., Lane, D.P., Chen, J. and Peng, J. (2013) Def defines a conserved nucleolar pathway that leads p53 to proteasome-independent degradation. Cell Res., 23, 620-634.
9. Fougerousse, F., Durand, M., Suel, L., Pourquié, O., Delezoide, A.L., Romero, N.B., Abitbol, M. and Beckmann, J.S. (1998) Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development. Genomics, 48, 145-156.
10. Ojima, K., Ono, Y., Hata, S., Koyama, S., Doi, N. and Sorimachi, H. (2005) Possible functions of p94 in connectin-mediated signaling pathways in skeletal muscle cells. J. Muscle Res. Cell Motil., 26, 409-417.
11. Baghdiguian, S., Martin, M., Richard, I., Pons, F., Astier, C., Bourg, N., Hay, R.T., Chemaly, R., Halaby, G., Loiselet, J. et al. (1999) Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IαBa/NF-κB pathway in limb-girdle muscular dystrophy type 2A. Nat. Med., 5, 503-511.
12. Kramerova, I., Kudryashova, E., Wu, B., Ottenheijm, C., Granzier, H. and Spencer, M.J. (2008) Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle. Hum. Mol. Genet., 17, 3271-3280.
13. Ojima, K., Kawabata, Y., Nakao, H., Nakao, K., Doi, N., Kitamura, F., Ono, Y., Hata, S., Suzuki, H., Kawahara, H. et al. (2010) Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy. J. Clin. Invest., 120, 2672-2683.
14. Kinbara, K., Sorimachi, H., Ishiura, S. and Suzuki, K. (1997) Muscle-specific calpain, p94, interacts with the extreme Cterminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. Arch. Biochem. Biophys., 342, 99-107.
15. Kolmerer, B., Olivieri, N., Witt, C.C., Herrmann, B.G. and Labeit, S. (1996) Genomic organization of M line titin and its tissue-specific expression in two distinct isoforms. J. Mol. Biol., 256, 556-563.
16. Kramerova, I., Kudryashova, E., Tidball, J.G. and Spencer, M.J. (2004) Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum. Mol. Genet., 13, 1373-1388.
17. Hackman, P., Vihola, A., Haravuori, H., Marchand, S., Sarparanta, J., De Seze, J., Labeit, S., Witt, C., Peltonen, L., Richard, I. et al. (2002) Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletalmuscle protein titin. Am. J. Hum. Genet., 71, 492-500.
18. Udd, B., Vihola, A., Sarparanta, J., Richard, I. and Hackman, P. (2005) Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology, 64, 636-642.
19. Udd, B., Partanen, J., Halonen, P., Falck, B., Hakamies, L., Heikkilä, H., Ingo, S., Kalimo, H., Kääriäinen, H., Laulumaa, V. et al. (1993) Tibial muscular dystrophy. Late adult-onset distal myopathy in 66 Finnish patients. Arch. Neurol., 50, 604-608.
20. Van den Bergh, P.Y., Bouquiaux, O., Verellen, C., Marchand, S., Richard, I., Hackman, P. and Udd, B. (2003) Tibial muscular dystrophy in a Belgian family. Ann. Neurol., 54, 248-251.
21. Hackman, P., Marchand, S., Sarparanta, J., Vihola, A., Pénisson-Besnier, I., Eymard, B., Pardal-Fernández, J.M., Hammouda el, H., Richard, I., Illa, I. et al. (2008) Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD). Neuromuscul. Disord., 18, 922-928.
22. Pénisson-Besnier, I., Hackman, P., Suominen, T., Sarparanta, J., Huovinen, S., Richard-Crémieux, I. and Udd, B. (2010) Myopathies caused by homozygous titin mutations: limb-girdle muscular dystrophy 2J and variations of phenotype. J. Neurol. Neurosurg. Psychiatry, 81, 1200-1202.
23. Pollazzon, M., Suominen, T., Penttilä, S., Malandrini, A., Carluccio, M.A., Mondelli, M., Marozza, A., Federico, A., Renieri, A., Hackman, P. et al. (2010) The first Italian family with tibial muscular dystrophy caused by a novel titin mutation. J. Neurol., 257, 575-579.
24. Evilä, A., Vihola, A., Sarparanta, J., Raheem, O., Palmio, J., Sandell, S., Eymard, B., Illa, I., Rojas-Garcia, R., Hankiewicz, K. et al. (2014) Atypical phenotypes in titinopathies explained by second titin mutations. Ann. Neurol., 75, 230-240.
25. Rudloff, M.W., Woosley, A.N. and Wright, N.T. (2015) Biophysical characterization of naturally occurring titin M10 mutations. Protein Sci. doi:10.1002/pro.2670.
26. Sauer, F., Vahokoski, J., Song, Y.H. and Wilmanns, M. (2010) Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin. EMBO Rep., 11, 534-540.
27. Pernigo, S., Fukuzawa, A., Bertz, M., Holt, M., Rief, M., Steiner, R.A. and Gautel, M. (2010) Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. Proc. Natl Acad. Sci. USA, 107, 2908-2913.
28. Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C. et al. (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell, 81, 27-40.
29. Charton, K., Danièle, N., Vihola, A., Roudaut, C., Gicquel, E., Monjaret, F., Tarrade, A., Sarparanta, J., Udd, B. and Richard, I. (2010) Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies. Hum. Mol. Genet., 19, 4608-4624.
30. Haravuori, H., Vihola, A., Straub, V., Auranen, M., Richard, I., Marchand, S., Voit, T., Labeit, S., Somer, H., Peltonen, L. et al. (2001) Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology, 56, 869-877.
31. de Morrée, A., Lutje Hulsik, D., Impagliazzo, A., van Haagen, H.H., de Galan, P., van Remoortere, A., t Hoen, P.A., van Ommen, G.B., Frants, R.R. and van der Maarel, S.M. (2010) Calpain 3 is a rapid-action, unidirectional proteolytic switch central to muscle remodeling. PLoS ONE, 5, e11940.
32. Zastrow, M.S., Flaherty, D.B., Benian, G.M. and Wilson, K.L. (2006) Nuclear titin interacts with A-and B-type lamins in vitro and in vivo. J. Cell Sci., 119, 239-249.
33. Obermann, W.M., Gautel, M., Steiner, F., van der Ven, P.F., Weber, K. and Fürst, D.O. (1996) The structure of the sarcomeric M band: localization of defined domains of myomesin, M-protein, and the 250-kD carboxy-terminal region of titin by immunoelectron microscopy. J. Cell Biol., 134, 1441-1453.
34. Goll, D.E., Thompson, V.F., Li, H., Wei, W. and Cong, J. (2003) The calpain system. Physiol. Rev., 83, 731-801.
35. Liu, Z., Cao, J., Gao, X., Ma, Q., Ren, J. and Xue, Y. (2011) GPSCCD: a novel computational programfor the prediction of calpain cleavage sites. PLoS ONE, 6, e19001.
36. Tompa, P., Buzder-Lantos, P., Tantos, A., Farkas, A., Szilágyi, A., Bánóczi, Z., Hudecz, F. and Friedrich, P. (2004) On the sequential determinants of calpain cleavage. J. Biol. Chem., 279, 20775-20785.
37. Rouillon, J., Zocevic, A., Leger, T., Garcia, C., Camadro, J.M., Udd, B., Wong, B., Servais, L., Voit, T. and Svinartchouk, F. (2014) Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy. Neuromuscul. Disord., 24, 563-573.
38. 2+ dependency of calpain 3 (p94) activation. Biochemistry, 45, 3714-3722.
39. Ermolova, N., Kramerova, I. and Spencer, M.J. (2015) Autolytic activation of calpain 3 proteinase is facilitated by calmodulin protein. J. Biol. Chem., 290, 996-1004.
40. 2+] and is not dependent on stretch. J. Biol. Chem., 284, 7811-7819.
41. Murphy, R.M., Goodman, C.A., McKenna, M.J., Bennie, J., Leikis, M. and Lamb, G.D. (2007) Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise. J. Appl. Physiol., 103, 926-931.
42. Murphy, R.M., Vissing, K., Latchman, H., Lamboley, C., McKenna, M.J., Overgaard, K. and Lamb, G.D. (2011) Activation of skeletal muscle calpain-3 by eccentric exercise in humans does not result in its translocation to the nucleus or cytosol. J. Appl. Physiol., 111, 1448-1458.
43. Kramerova, I., Kudryashova, E., Venkatraman, G. and Spencer, M.J. (2005) Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum. Mol. Genet., 14, 2125-2134.
44. Sorimachi, H., Toyama-Sorimachi, N., Saido, T.C., Kawasaki, H., Sugita, H., Miyasaka, M., Arahata, K., Ishiura, S. and Suzuki, K. (1993) Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J. Biol. Chem., 268, 10593-10605.
45. Sorimachi, H., Kinbara, K., Kimura, S., Takahashi, M., Ishiura, S., Sasagawa, N., Sorimachi, N., Shimada, H., Tagawa, K., Maruyama, K. et al. (1995) Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J. Biol. Chem., 270, 31158-31162.
46. Kinbara, K., Ishiura, S., Tomioka, S., Sorimachi, H., Jeong, S.Y., Amano, S., Kawasaki, H., Kolmerer, B., Kimura, S., Labeit, S. et al. (1998) Purification of native p94, amuscle-specific calpain, and characterization of its autolysis. Biochem. J., 335, 589-596.
47. Ono, Y., Torii, F., Ojima, K., Doi, N., Yoshioka, K., Kawabata, Y., Labeit, D., Labeit, S., Suzuki, K., Abe, K. et al. (2006) Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system. J. Biol. Chem., 281, 18519-18531.
48. Sarparanta, J., Blandin, G., Charton, K., Vihola, A., Marchand, S., Milic, A., Hackman, P., Ehler, E., Richard, I. and Udd, B. (2010) Interactions with M-band titin and calpain 3 linkmyospryn (CMYA5) to tibial and limb-girdle muscular dystrophies. J. Biol. Chem., 285, 30304-30315.
49. Reynolds, J.G., McCalmon, S.A., Tomczyk, T. and Naya, F.J. (2007) Identification and mapping of protein kinase A binding sites in the costameric protein myospryn. Biochim. Biophys. Acta, 1773, 891-902.
50. Kielbasa, O.M., Reynolds, J.G., Wu, C.L., Snyder, C.M., Cho, M. Y., Weiler, H., Kandarian, S. and Naya, F.J. (2011) Myospryn is a calcineurin-interacting protein that negatively modulates slow-fiber-type transformation and skeletal muscle regeneration. FASEB J., 25, 2276-2286.
51. Prudner, B.C., Roy, P.S., Damron, D.S. and Russell, M.A. (2014) a-Synemin localizes to the M-band of the sarcomere through interaction with the M10 region of titin. FEBS Lett., 588, 4625-4630.
52. Fukuzawa, A., Lange, S., Holt, M., Vihola, A., Carmignac, V., Ferreiro, A., Udd, B. and Gautel, M. (2008) Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies. J. Cell Sci., 121, 1841-1851.
53. Bagnato, P., Barone, V., Giacomello, E., Rossi, D. and Sorrentino, V. (2003) Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles. J. Cell Biol., 160, 245-253.
54. Armani, A., Galli, S., Giacomello, E., Bagnato, P., Barone, V., Rossi, D. and Sorrentino, V. (2006) Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum. Exp. Cell Res., 312, 3546-3558.
55. Kravchenko, I.V., Furalyov, V.A., Chatziefthimiou, S., Wilmanns, M. and Popov, V.O. (2015) Induction of insulin-like growth factor 1 splice forms by subfragments of myofibrillar proteins. Mol. Cell. Endocrinol., 399, 69-77.
56. Kravchenko, I.V., Furalyov, V.A. and Popov, V.O. (2012) Stimulation of mechano-growth factor expression by myofibrillar proteins in murine myoblasts and myotubes. Mol. Cell. Biochem., 363, 347-355.
57. Ali, M.A., Cho, W.J., Hudson, B., Kassiri, Z., Granzier, H. and Schulz, R. (2010) Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation, 122, 2039-2047.
58. Taveau, M., Stockholm, D., Spencer, M. and Richard, I. (2002) Quantification of splice variants using molecular beacon or scorpion primers. Anal. Biochem., 305, 227-235.
59. Carmignac, V., Salih, M.A., Quijano-Roy, S., Marchand, S., Al Rayess, M.M., Mukhtar, M.M., Urtizberea, J.A., Labeit, S., Guicheney, P., Leturcq, F. et al. (2007) C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann. Neurol., 61, 340-351.
60. Herman, D.S., Lam, L., Taylor, M.R., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S.R., McDonough, B., Sparks, E. et al. (2012) Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med., 366, 619-628.
61. Ceyhan-Birsoy, O., Agrawal, P.B., Hidalgo, C., Schmitz-Abe, K., DeChene, E.T., Swanson, L.C., Soemedi, R., Vasli, N., Iannaccone, S.T., Shieh, P.B. et al. (2013) Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology, 81, 1205-1214.
62. Chauveau, C., Bonnemann, C.G., Julien, C., Kho, A.L., Marks, H., Talim, B., Maury, P., Arne-Bes, M.C., Uro-Coste, E., Alexandrovich, A. et al. (2014) Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Hum. Mol. Genet., 23, 980-991.
63. Roberts, A.M., Ware, J.S., Herman, D.S., Schafer, S., Baksi, J., Bick, A.G., Buchan, R.J., Walsh, R., John, S., Wilkinson, S. et al. (2015) Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci. Transl. Med., 7, 270ra6.
64. Richard, I., Roudaut, C., Marchand, S., Baghdiguian, S., Herasse, M., Stockholm, D., Ono, Y., Suel, L., Bourg, N., Sorimachi, H. et al. (2000) Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IαBa/nuclear factor κB pathway perturbation in mice. J. Cell Biol., 151, 1583-1590.
65. Fougerousse, F., Gonin, P., Durand, M., Richard, I. and Raymackers, J.M. (2003) Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption. Muscle Nerve, 27, 616-623.